Not all Covid waves look the same. Here’s a snapshot of the Delta surge
At first, Joyce Dombrouski thought it might just be some kind of blip. Maybe it…
Author: STAT
Opinion: STAT+: Why does the FDA want to stop improving medicines via patent ‘areas of concern’?
It’s hardly unprecedented for one federal agency to encroach on another’s turf. But the latest intra-executive-branch…
Rochelle Walensky said she’d ‘fix’ the CDC, but nine months in, she’s faltering
WASHINGTON — Operating via Zoom from her home office in Newton, Mass., Rochelle Walensky is…
STAT+: Moderna millionaires and the double-edged sword of stock market riches
In just a few years, Moderna went from stock market dud to moonshot, a prime example…
STAT+: New court rulings add to the confusing and controversial dispute over a U.S. drug discount program
In the latest twist in a closely watched legal battle, two different federal court judges…
Opinion: The hurried push by Congress to address drug costs shouldn’t undermine the vast savings from generics and biosimilars
Americans rightfully expect Congress to address the ever-increasing prices of brand-name prescription drugs. But the…
STAT+: Clinical trial sites face challenges in diversifying personnel and participants, study finds
As demands for diversity and equity increase across the globe, a new analysis finds nearly…
STAT+: Pharmalittle: Pfizer pill reduced deaths in newly diagnosed Covid patients; U.S. cancels contract with Emergent
Good morning, and a fine Friday to you from STAT reporter Andrew Joseph, here filling…
Experimental Pfizer pill prevents Covid hospitalizations and deaths
An experimental antiviral pill developed by Pfizer reduced the risk of death and hospitalization by…
Opinion: Is the debate over the origin of Covid-19 still worth having?
The American public is understandably interested in how a pandemic that has killed nearly 750,000…
Opinion: I worry that burnout can’t be reversed and has fundamentally changed me as a doctor and a person
It took me four months to write this sentence. I wanted to capture my feelings…
STAT+: John Maraganore on what comes next for Alnylam and his career
This interview is an excerpt from a recent segment on “The Readout LOUD.” Listen to…
Listen: Moderna’s setback, the saga of drug pricing reform & a CEO’s next act
Is drug pricing reform actually happening? Why was Moderna’s stock down? And what’s next for…
STAT+: Alphabet has a new drug discovery company building on DeepMind’s AI chops
Alphabet is plunging into the drug discovery business. Over the last year, the tech behemoth…
STAT+: Pharmalittle: Moderna sees $18 billion in Covid vaccine sales despite production woes; U.K. clears Merck Covid pill
Good morning, folks. And how are you today? We are in fine spirits, thanks to…
Merck’s Covid-19 antiviral pill receives first authorization in U.K.
LONDON — Britain granted conditional authorization on Thursday to the first pill shown to successfully…
STAT+: CAR-T therapies from Bristol, Gilead superior to standard treatment in blood cancer, studies show
Administering bespoke CAR-T cell therapies from Bristol Myers Squibb or Gilead Sciences provides greater benefit…
White House delays Covid-19 vaccine mandates for federal employees, contractors
The White House is delaying its mandate for federal workers and contractors to get vaccinated…
Opinion: Time, facial feminization, and the transgender experience
Time, a precious commodity for all of us, poses extra challenges for transgender people. Every…
.jpg)
Opinion: What Moderna owes the world
Moderna is expected to reveal its third quarter earnings on Nov. 4. The announcement will…
STAT+: Alzheimer’s conference preview: Aduhelm debate persists, while field grapples with new targets and directions
When physicians and scientists involved in Alzheimer’s disease gather in Boston next week for an…
STAT+: ‘The beginning of a long journey’: A progress report on Big Retail’s ambitions in health care
When Mark Wahlberg helped ring in the grand opening of Walmart’s second health clinic in…
STAT+: Scientists find a clue to why some people have ‘Alzheimer’s brains’ but no dementia
Defective proteins clump into toxic plaques and tangles. Plaques of amyloid and tau tangles kill…
STAT+: Pharmalittle: Democrats reach a deal on drug pricing; CDC OKs Pfizer Covid shot for kids ages 5 to 11
Rise and shine, everyone, another busy day is on the way. Yes, indeed, the middle…
Opinion: Listen: An antibiotic expert on her body’s stinging betrayal
Natalie Ma knows a lot about antibiotics. She’s familiar with the consequences of antibiotic resistance…
Opinion: Molnupiravir: another Covid-19 treatment, another opportunity to recognize inequity
The Covid-19 pandemic has disproportionately affected communities of color and those with lower socioeconomic means,…
.jpg)
Mandates. A well-organized campaign. No politics. How Puerto Rico’s vaccine drive turned into a success
The leader of the Puerto Rico National Guard was still dealing with the aftermath of…
Here’s who wins and loses in Democrats’ new prescription drug pricing deal
WASHINGTON — Congressional Democrats on Tuesday announced they had agreed to a broad plan to overhaul…
CDC advisers endorse Pfizer’s Covid-19 vaccine for kids 5-11
Children aged 5 to 11 can begin to be vaccinated against Covid-19 within the next…
Democrats circulate a new drug pricing outline with a big carveout for small biotechs
WASHINGTON — A proposed version of drug pricing legislation circulating among Capitol Hill aides and…
STAT+: Pharmalittle: Pfizer expects $36 billion in Covid-19 vaccine sales this year; Dems scramble for a drug-pricing compromise
Top of the morning to you. Gray skies are hovering over the Pharmalot campus right…
Opinion: I’ve worked with Robert Califf. He is the leader the FDA needs
If the cascade of news reports are true, President Biden is finally about to name…
STAT+: STAT+ Conversation: Intelligence about artificial intelligence
Editor’s note: A livestream of the conversation will be embedded below at 1 p.m. ET….
Here’s where Democrats’ resurrected drug pricing talks are headed
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…
STAT+: Moderna, making billions from its vaccine, bets on a genome-editing startup
Moderna, flush with cash thanks to its blockbuster Covid-19 vaccine, made waves back in August…
STAT+: Could Robert Califf’s ties to tech complicate his FDA nomination?
WASHINGTON — Robert Califf spent his first confirmation hearing explaining his entanglements with the drug…
Opinion: Make Covid-19 testing an empowering choice rather than a draconian punishment
Public health is at its best when it is pragmatic in the face of complex…
‘There was no plan’: Throwing spaghetti at the wall to overcome Covid-19 vaccine hesitancy
One or two donuts, a car, one million dollars, $25, Super Bowl tickets, french fries….
STAT+: With two new insurance partnerships, EQRx takes its first steps toward lowering drug prices. But how big are those steps?
EQRx — the buzzy biotech company with a lofty mission of making far less expensive…
STAT+: In a first, a California judge rules drug makers are not liable for the opioid crisis
For the first time, drug makers won a court victory in the massive litigation over…
STAT+: Pharmalittle: Doctors pushing Alzheimer’s drug have ties to Biogen; pharma wins key round in dispute over hospital discounts
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Centessa drug shows early promise for inherited lung disease, but liver safety issue seen in small study
An experimental “corrector” drug from Centessa Pharmaceuticals normalized the levels of a target protein in…
Opinion: Had I done Ancestry.com sooner, I could have gotten a kidney transplant two years earlier
For the past few years, experts have criticized — and defended — the use of…
A smart knee implant promises to ‘help write the future of orthopedic technology.’ Surgeons aren’t so sure
Last month, surgeons implanted the first of a new, souped-up knee implant, developed by Zimmer…
STAT+: The Purdue bankruptcy plan was approved to distribute billions. Where is the money?
Nearly two months ago, a U.S. bankruptcy court judge approved a controversial Purdue Pharma plan…
STAT+: The loudest physician proponents of Aduhelm have all taken money from Biogen
WASHINGTON — A small group of physicians with deep, at times undisclosed, financial ties to…
STAT+: Government’s bid to force drug makers to offer discounts to some hospitals was ‘arbitrary and capricious,’ judge rules
After more than a year of controversy, a federal court judge ruled the U.S. government…
FDA authorizes Pfizer Covid-19 vaccine for children aged 5 to 11
The Food and Drug Administration granted emergency use authorization to the Covid-19 vaccine developed by…
Can a pro-Covid vaccine, anti-mandate position help a Republican win in a Democratic state?
Glenn Youngkin is playing both sides on Covid-19 vaccines. In his effort to win Virginia’s…
STAT+: Pharmalittle: Pelosi tries last-ditch drug pricing proposal; Merck sees up to $7B in Covid pill sales in 2022
And so, another working week will soon draw to a close. Not a moment too…